Skip to main content

Compared strategies of carotid revascularization periprocedural risks and long-term outcomes: a systematic review and meta-analysis of randomized trials of stenting versus endarterectomy

In brief

Stenting raised 30-day stroke or death from 3.4% to 4.6% versus surgery

In six randomized cohorts, carotid stenting was linked to 1.2 percentage points more strokes or deaths within 30 days than endarterectomy; strokes were also more frequent, while heart attacks and cranial nerve injuries were less frequent. Longer-term stroke outcomes did not differ significantly, but varied definitions and follow-up limit what the comparison can establish.

Journal
Neurosurgical review (Q1)
Published
20 November 2026
Study design
Systematic review / meta-analysis of RCTs
Evidence level
Level 1, High (CEBM 1a)
Authors
Sudhanva R Rao, Matthan Tharakan, Benjamin C Chou, Uttam Verma, Hakeem J Shakir, M Burhan Janjua
PMID
43062745
DOI
10.1007/s10143-026-04578-2

Why clinicians should know about it

  • Picked for Neurology (clinical) (paper of the day, 22 November 2026): Randomized-trial synthesis compares carotid stroke-prevention procedures

Abstract

OBJECTIVE: Carotid endarterectomy (CEA) remains the benchmark open revascularization strategy for appropriately selected patients with extracranial carotid stenosis, whereas carotid artery stenting (CAS) provides an endovascular alternative when cervical exposure, medical comorbidity, or anatomic factors make open surgery less favorable. Balancing periprocedural stroke, myocardial infarction, cranial nerve injury, and long-term stroke risk remains central to contemporary cerebrovascular decision-making. This study compared periprocedural and exploratory long-term outcomes after CAS versus CEA using randomized head-to-head trial evidence across trial eras. METHODS: PubMed, EMBASE, CENTRAL, and ClinicalTrials.gov were searched through April 2026. Eligible studies were randomized trials directly comparing CAS with CEA in adults with extracranial carotid stenosis. Arm-level event counts were extracted. Random-effects risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using inverse-variance models with DerSimonian-Laird estimation. Hartung-Knapp intervals and absolute risk differences were added to support sensitivity analysis and clinical interpretation. The primary endpoint was 30-day stroke or death. Secondary endpoints included periprocedural stroke, death, myocardial infarction (MI), cranial nerve injury, disabling stroke or death, and exploratory long-term stroke-related outcomes. RESULTS: Six randomized cohorts contributed to the primary endpoint; up to eight contributed to secondary analyses. Thirty-day stroke or death occurred in 244 of 5285 patients assigned to CAS (4.6%) and 156 of 4522 assigned to CEA (3.4%), corresponding to an absolute excess of 1.2 percentage points with CAS and a pooled RR of 1.42 (95% CI, 1.12-1.81; I²=27.9%). Periprocedural stroke was also more common after CAS (291/6305 [4.6%] vs. 186/5546 [3.4%]; RR, 1.44; 95% CI, 1.18-1.75; I²=9.1%). Periprocedural death did not differ significantly (RR, 1.30; 95% CI, 0.77-2.19). MI (RR, 0.45; 95% CI, 0.29-0.71) and cranial nerve injury (RR, 0.05; 95% CI, 0.02-0.11) favored CAS. In a prespecified sensitivity analysis excluding CAVATAS-because most patients in its endovascular arm underwent balloon angioplasty rather than stenting-the primary result was unchanged (RR, 1.51; 95% CI, 1.17-1.95). Exploratory long-term stroke-related outcomes did not differ significantly (RR, 1.05; 95% CI, 0.87-1.26), although endpoint definitions and follow-up windows varied substantially. CONCLUSIONS: In randomized head-to-head trials, CAS was associated with higher early stroke and stroke-or-death risk than CEA, whereas MI and cranial nerve injury were reported less often after CAS. Selection of open versus endovascular carotid revascularization should be guided by symptom status, age, lesion morphology, cervical and arch anatomy, perioperative cardiac risk, and operator outcomes.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.